Braskem S.A. (NYSE: BAK) Faces Downgrade and Legal Investigation Amid Financial Concerns

Grupo Santander downgraded Braskem S.A. (NYSE: BAK) from "Neutral" to "Underperform" due to ongoing financial health and strategic direction concerns.Pomerantz LLP is investigating Braskem for potential securities fraud following a significant drop in ADR price after announcing the exploration of financial alternatives.Despite recent challenges, Braskem's stock shows resilience with a slight increase, amidst significant volatility over the past year.Braskem S.A. (NYSE: BAK) is a leading petrochemical compan ...